Moderna/ US60770K1079 /
| 2024-12-20 9:59:59 PM | Chg. -0.16 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 39.38USD | -0.40% | 221,190 Turnover: 8.85 mill. |
-Bid Size: - | -Ask Size: - | 15.16 bill.USD | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -12.33 USD | -158.00% |
| EPS Diluted: | -12.33 USD | - |
| Revenues per Share: | 17.92 USD | -64.05% |
| Book Value per Share: | 36.26 USD | -26.74% |
| Cash Flow per Share: | -8.16 USD | - |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 6,848.00 USD | -64.45% |
| Net Income: | -4,714.00 USD | -156.37% |
| Operating Cash Flow: | -3,118.00 USD | - |
| Cash and Cash Equivalents: | 2,907.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 2.20 | 5.55 |
| P/BV ratio: | 1.09 | 2.74 |
| P/CF Ratio: | -4.83 | -12.19 |
| PEG: | 0.02 | - |
| Earnings Yield: | -31.30% | -12.40% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 15.16 bill. USD | 38 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 384.82 mill. | |
Profitability
| Gross Profit Margin: | 31.47% |
| EBIT Margin: | -61.90% |
| Net Profit Margin: | -68.84% |
| Return on Equity: | -34.03% |
| Return on Assets: | -25.58% |
Financial Strength
| Liquidity I / Cash Ratio: | 0.96% |
| Liquidity II / Quick Ratio: | 1.26% |
| Liquidity III / Current Ratio: | 3.42% |
| Debt / Equity Ratio: | 0.04% |
| Dynam. Debt / Equity Ratio: | -146.63% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
